Rivista di formazione e aggiornamento professionale del pediatra e del medico di base, fondata nel 1982. In collaborazione con l'Associazione Culturale Pediatri.
Login Abbonamenti Pubblicazioni Carrello Registrazione Perché registrarsi? Contatti

obliterative bronchiolitis

2 articoli — 2015-2021

RI Farmacoriflessioni
Tutto quello che il pediatra dovrebbe sapere sul mepolizumab

Prisco A, Carlone G, Maschio M, Badina L, Barbi E

2021/6 — pag. 374-378 — DOI

Mepolizumab, a monoclonal antibody blocking IL-5, is efficacious in the treatment of severe lung diseases sharing eosinophilic inflammation pattern. The paper describes two cases in which the drug was used with excellent results. The first involved a...

EL Caso contributivo
Un lobo polmonare iperlucente

G. Vieni, S. Pusceddu, L. Mambelli, F. Pugliese, V. Poletti, F. Marchetti

2015/9

The paper describes the case of a 7-year-old female child with a history of chronic cough following an acute respiratory infection and unilateral hyperlucent lung on chest radiograph. The diagnosis was Swyer-James-MacLeod syndrome, based on character...

Argomenti correlati
Asthma (268) Adrenal Cortex Hormones (256) Cough (69) Tomography, X-Ray Computed (68) Eosinophilia (57) Off-Label Use (33) Eosinofilia (27) Lung Diseases (15) Radiography, Thoracic (13) Bronchiectasis (12) Antibodies, Monoclonal, Humanized (12) Bronchiolitis obliterans (7) Chronic lung disease (7) anticorpo monoclonale (6) Monoclonal antibody (5) Air trapping (4) Bronchiolite obliterante (4) Mepolizumab (3) Interleukin-5 (3) Non-atopic asthma (2)